Diabetes Care, Vol 23, Issue 6 775-778, Copyright © 2000 by American Diabetes Association

ARTICLES

Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians

RA Hegele, H Cao, AJ Hanley, B Zinman, SB Harris and CM Anderson
John P. Robarts Research Institute, and Department of Medicine, University of Western Ontario, London, Canada. robert.hegele@rri.on.ca

OBJECTIVE: To determine the diagnostic performance characteristics of HNF1A genotyping for diabetes and impaired glucose tolerance (IGT) in Canadian Oji-Cree Indians. RESEARCH DESIGN AND METHODS: We studied all Oji-Cree subjects > or = 50 years of age (96 subjects) who had participated in a community-wide prevalence survey for type 2 diabetes. Subjects were classified either as having "disease," which included type 2 diabetes and IGT, or not. All subjects were genotyped for the HNF1A G319S mutation. RESULTS: The prevalence of disease in this group was 65.7%, of whom 71.4% had type 2 diabetes. For a carrier of HNF1A S319, the specificity, sensitivity, and positive and negative predictive values were 97.0, 30.1, 95.0, and 42.1%, respectively. When the pretest disease prevalence was accounted for, the probability of disease after a positive test was 97.2%, and the probability of disease after a negative test was 42.2%. The values were very similar for the subgroup of subjects with type 2 diabetes alone. CONCLUSIONS: The HNF1A genotype appears to be the most specific genetic test yet reported for the prediction of a common multifactorial disease by applying present-day standards of clinical epidemiology in molecular genetics. A positive test result had particular diagnostic value in the Oji-Cree: a subject with HNF1A S319 was virtually certain of having diabetes or IGT by 50 years of age. In contrast, a subject without HNF1A S319 had a reduced risk compared with the age-specific prevalence but was not totally risk-free. Because HNF1A S319 was not the only predisposing factor for diabetes in the Oji-Cree, subjects without HNF1A S319 were still at some risk for diabetes or IGT.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Carpentier, B. Zinman, N. Leung, A. Giacca, A. J.G. Hanley, S. B. Harris, R. A. Hegele, and G. F. Lewis Free Fatty Acid-Mediated Impairment of Glucose-Stimulated Insulin Secretion in Nondiabetic Oji-Cree Individuals From the Sandy Lake Community of Ontario, Canada: A Population at Very High Risk for Developing Type 2 Diabetes Diabetes, June 1, 2003; 52(6): 1485 - 1495. [Abstract] [Full Text] [PDF]

				B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community PNAS, April 2, 2002; 99(7): 4614 - 4619. [Abstract] [Full Text] [PDF]

				B. L. Triggs-Raine, R. D. Kirkpatrick, S. L. Kelly, L. D. Norquay, P. A. Cattini, K. Yamagata, A. J. G. Hanley, B. Zinman, S. B. Harris, P. H. Barrett, et al. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community PNAS, April 2, 2002; 99(7): 4614 - 4619. [Abstract] [Full Text] [PDF]